Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Impel Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Impel Pharmaceuticals

Impel Pharmaceuticals

Public

Impel NeuroPharma: A Seattle-based medical firm innovating CNS disease therapies via unique nasal drug delivery.

HQ
Seattle, WA, US
Founded
2008
Overview
Compare
Employees
Website

Impel Pharmaceuticals, founded in Seattle, Washington, is dedicated to creating innovative therapies for central nervous system (CNS) diseases. The company's core mission is to address unmet medical needs through transformative treatments. Impel's flagship product is based on their proprietary POD™ device, a novel nasal drug delivery platform designed to administer medication directly to the upper nasal cavity, enhancing efficacy and patient outcomes.

Notable figures associated with Impel Pharmaceuticals include key investors from the biotech and pharmaceutical sectors. The company has achieved significant milestones, including the successful development and commercialization of its unique drug delivery system. Impel's impact lies in its ability to offer new hope and improved quality of life for patients with challenging CNS conditions, positioning itself as a disruptive force in the pharmaceutical industry.

Impel Pharmaceuticals - Similar Companies

Neurana Pharmaceuticals logo

Neurana Pharmaceuticals

neuranapharma.com

Supernus Pharmaceuticals logo

Supernus Pharmaceuticals

supernus.com

ARS Pharmaceuticals logo

ARS Pharmaceuticals

ars-pharma.com

PIN Pharma logo

PIN Pharma

pinpharma.com

PleoPharma logo

PleoPharma

pleopharma.com

Bryn Pharma logo

Bryn Pharma

brynpharma.com

Avalyn Pharma logo

Avalyn Pharma

avalynpharma.com

Aptinyx logo

Aptinyx

aptinyx.com

Durect logo

Durect

durect.com

Collegium Pharmaceutical logo

Collegium Pharmaceutical

Edison Pharmaceuticals logo

Edison Pharmaceuticals

Amphastar Pharmaceuticals logo

Amphastar Pharmaceuticals

amphastar.com

Aquestive Therapeutics logo

Aquestive Therapeutics

aquestive.com

Vanda Pharmaceuticals logo

Vanda Pharmaceuticals

Woolsey Pharmaceuticals logo

Woolsey Pharmaceuticals

woolseypharma.com

Impel Pharmaceuticals - Quick Facts

Who are Impel Pharmaceuticals' competitors?

Companies similar to Impel Pharmaceuticals include Neurana Pharmaceuticals, Supernus Pharmaceuticals, ARS Pharmaceuticals and PIN Pharma.

When was Impel Pharmaceuticals founded?

Impel Pharmaceuticals was founded in 2008.

Where is Impel Pharmaceuticals' headquarters located?

Impel Pharmaceuticals' headquarters is located in Seattle, WA, US.

How many employees does Impel Pharmaceuticals have?

Impel Pharmaceuticals has 119 employees as of Feb 6, 2024.

Impel Pharmaceuticals - Classification

Industry
  • Hardware
Ownership
  • Venture Capital
Technology
  • Drug Delivery
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Pharmaceuticals
Tags
  • Biotech
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 14 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 4000Railroad Transportation
  • 8000Health Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research